Amwill Healthcare IPO
smelistedAbout the company
Amwill Healthcare specializes in developing dermatological, cosmeceutical, and aesthetic products, collaborating with contract manufacturers and third-party agencies for production, packaging, and distribution. The company focuses on both generic dermatological solutions and unique formulations for issues like acne, anti-aging, and fungal infections. Operating in Karnataka, Andhra Pradesh, and Telangana, Amwill plans to expand further. With a strong management team and partnerships with dermatologists, they aim for continued growth and market success.
Strengths
Risks
Financial performance (₹ Cr)
Subscription breakup (final, times)
IPO Roadmap / Timeline
IPO Opens
Completed05 Feb 2025Bidding starts for all investor categories
IPO Closes
Completed07 Feb 2025Last day to place your bid
Basis of Allotment
Completed10 Feb 2025Share allotment finalised
Refund Initiation
Completed11 Feb 2025Refunds credited for non-allottees
Credit to Demat
Completed11 Feb 2025Allotted shares credited to demat account
Listing on Exchange
Completed12 Feb 2025Shares list on NSE / BSE
Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.
Lot size & minimum investment
| Investor Type | Min Lots | Min Shares | Min Amount | Max Lots | Max Amount | Notes |
|---|---|---|---|---|---|---|
| Retail / Individual | 1 | 1200 | ₹133,200 | 1 | ₹133,200 | 1 lot only |
| HNI | 2 | 2400 | ₹266,400 | 2 | ₹266,400 | Min 2 lots |
Shares reserved per category & allotment probability
| Category | Reservation | Shares Offered | Amount (₹ Cr) | Shares Bid | Subscribed | Allotment % |
|---|---|---|---|---|---|---|
| QIB | 50% | 2,731,482 | 29.5 | 0 | 0.00x | 100% |
| NII | 15% | 819,444 | 8.85 | 0 | 0.00x | 100% |
| Retail | 35% | 1,912,037 | 20.65 | 0 | 0.00x | 100% |
Retail is a lottery-based allotment when oversubscribed; QIB/NII get pro-rata. Probability ≈ 1 / subscription times (100% if under-subscribed).
